全文获取类型
收费全文 | 17468篇 |
免费 | 1018篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 153篇 |
儿科学 | 407篇 |
妇产科学 | 476篇 |
基础医学 | 2634篇 |
口腔科学 | 567篇 |
临床医学 | 1479篇 |
内科学 | 3362篇 |
皮肤病学 | 554篇 |
神经病学 | 1786篇 |
特种医学 | 549篇 |
外科学 | 2386篇 |
综合类 | 72篇 |
一般理论 | 7篇 |
预防医学 | 1130篇 |
眼科学 | 385篇 |
药学 | 1471篇 |
中国医学 | 32篇 |
肿瘤学 | 1097篇 |
出版年
2023年 | 121篇 |
2022年 | 167篇 |
2021年 | 245篇 |
2020年 | 188篇 |
2019年 | 244篇 |
2018年 | 342篇 |
2017年 | 352篇 |
2016年 | 409篇 |
2015年 | 407篇 |
2014年 | 490篇 |
2013年 | 607篇 |
2012年 | 1015篇 |
2011年 | 1016篇 |
2010年 | 534篇 |
2009年 | 465篇 |
2008年 | 911篇 |
2007年 | 898篇 |
2006年 | 898篇 |
2005年 | 920篇 |
2004年 | 839篇 |
2003年 | 787篇 |
2002年 | 798篇 |
2001年 | 508篇 |
2000年 | 500篇 |
1999年 | 426篇 |
1998年 | 187篇 |
1997年 | 144篇 |
1996年 | 114篇 |
1995年 | 108篇 |
1994年 | 102篇 |
1993年 | 74篇 |
1992年 | 205篇 |
1991年 | 175篇 |
1990年 | 193篇 |
1989年 | 177篇 |
1988年 | 162篇 |
1987年 | 139篇 |
1986年 | 143篇 |
1985年 | 132篇 |
1984年 | 116篇 |
1983年 | 107篇 |
1979年 | 113篇 |
1977年 | 72篇 |
1974年 | 83篇 |
1973年 | 75篇 |
1972年 | 80篇 |
1971年 | 75篇 |
1969年 | 98篇 |
1968年 | 93篇 |
1967年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Ohne ZusammenfassungHerrn Prof. Berger und Herrn Privatdocenten Dr. Marchand sage ich für die mir bei vorstehender Arbeit gewährte Unterstützung meinen herzlichsten Dank. 相似文献
32.
U. Bolm-Audorff S. Brandenburg T. Brüning H. Dupuis R. Ellegast G. Elsner K. Franz H. Grasshoff V. Grosser L. Hanisch B. Hartmann E. Hartung† K. G. Hering G. Heuchert M. Jäger J. Krämer Dr. A. Kranig E. Ludolph A. Luttmann A. Nienhaus W. Pieper K. D. Pöhl T. Remé D. Riede G. Rompe K. Schäfer S. Schilling E. Schmitt F. Schröter A. Seidler M. Spallek M. Weber 《Trauma und Berufskrankheit》2005,7(4):320-332
The first part of this serial paper dealt with the medical criteria used in evaluation of the clinical picture caused by physical stress and the evaluation of other candidate causes and was published in issue no. 3/2005 (pp. 711–752) of Trauma and Berufskrankheit. This follow-up paper (II) presents criteria to be used in the evaluation of whether it is necessary to give up the occupations putting the spine at risk and in estimation of the degree of disability. 相似文献
33.
34.
William A. Marston MD ; Anton Usala MD ; Ronald S. Hill PhD ; Robert Mendes MD ; Mary-Ann Minsley RN 《Wound repair and regeneration》2005,13(3):243-247
A novel injectable scaffolding matrix (E-Matrix) has been developed to accelerate wound healing in diabetic foot ulcers. This porcine collagen-derived matrix is designed to mimic tertiary embryonic connective tissue and to stimulate fetal wound repair mechanisms including angiogenesis. In vitro and animal studies have indicated a beneficial effect on tissue growth and an acceptable safety profile. In this report, we describe the initial use of this product in a pilot study of six humans with chronic nonhealing diabetic foot ulcers. A dramatic initial response to injection was seen, with an average wound size reduction of 72% 2 weeks after injection. Randomized trials are underway to define the potential benefit of this new treatment modality for diabetic foot ulcers. 相似文献
35.
Background - A case of primary thyroid T cell lymphoma leading to lethal tracheal perforation during chemotherapy is described. 相似文献
36.
Relation between kidney and liver in the excretion of drugs depends on the physicochemical properties of each substance tested. The calculations of this relationship are based on a so-called rank coefficient (0-100) calculated from molecular weight, lipophilicity, degree of dissociation under physiological conditions, and protein binding rate. The results of the correlation between one of these physicochemical values and drug elimination were stochastically. Experiments were performed with 9 test substances which were distinctly different concerning their physicochemical features. Substances with a rank coefficient less than 20 (low molecular weight, low lipophilicity, preferentially ionic at pH 7.4) are eliminated effectively via the kidney. Compounds having an intermediate rank coefficient (40-60) were quantitatively excreted into urine as well. For drugs with high ranks greater than 60 (high values of molecular weight, protein binding, and lipophilicity, almost exclusively nonionic), renal excretion can be neglected. Quite inverse relations between ranks and hepatic excretion have been found: low ranks indicate an ineffective secretion of the respective drug into bile. With increasing ranks (40-60), biliary excretion increases and reaches a maximum (approximately 40% of supply). This maximum is caused by limited hepatic blood flow and by the capacity of hepatic uptake carriers. Blockade of one elimination pathway (bilateral nephrectomy or bile duct ligation) is followed by a sufficient compensation of drug excretion via the alternative elimination route only, if the test substance belongs to the intermediate group (ranks between 40 and 60). For substances with high or low ranks a compensation of drug excretion can be excluded. 相似文献
37.
The pharmacokinetics and pharmacodynamics of the anticholinergic and calcium antagonistic drug terodiline, N-tert-butyl-1-methyl-3,3-diphenylpropylamine, have been studied in beagle dogs. The bioavailability was about 25% (0.15 and 0.5 mg/kg), the terminal half-life 3 hr, the systemic clearance 40 ml/min..kg, the volume of distribution (V beta) about 7 l/kg and the unbound fraction in serum 0.14. p-Hydroxyterodiline and p-hydroxy-m-methoxyterodiline were quantitated and constituted 15-40% and 25%, respectively, of the amount excreted in urine (about 60% of the dose) and were the main metabolites, as in man. The dog was used as an experimental model to study the chronotropic effect. An increased heart rate was observed after acute administration of high doses of terodiline as well as after p-hydroxyterodiline. A 20% increase in heart rate was observed at a mean serum concentration of 1086 and 1010 micrograms/l following intravenous injection of terodiline or p-hydroxyterodiline, respectively. The corresponding unbound concentrations were 150 and 474 micrograms/l. The potency ratios of terodiline/p-hydroxyterodiline was 0.9 +/- 0.2 (based on total concentrations) and 3.2 +/- 0.8 (based on unbound concentrations). The estimated potency of parent drug and main metabolite and the fact that p-hydroxyterodiline constitutes 10-20% of the terodiline steady-state level in man, indicate that the contribution of the metabolite to the chronotropic effect observed in clinical studies is minor. 相似文献
38.
K. Brøsen L. F. Gram P. N. Nielsen K. Brusgaard K. Skjødt 《European journal of clinical pharmacology》1994,47(3):221-225
CYP2D6 genotyping was carried out by XbaI restriction fragment length polymorphism analysis and polymerase chain reaction in 168 healthy Danish volunteers, 77 extensive metabolizers (EM) and 91 poor metabolizers (PM) of sparteine. All EM were genotyped correctly as heterozygous or homozygous for the functional (wild type) gene, D6-wt. However, the D6-wt gene was apparently also present in 11 (12%) of the PM who accordingly were incorrectly genotyped as EM. The specificity of genotyping PM thus was 100% but the sensitivity was only 88%. The most common allele was the D6-wt with an apparent frequency of 0.741 (0.026) in the Danish population and the second most common allele was the D6-B with an apparent frequency of 0.194 (0.024). The median (range) of the sparteine metabolic ratio (MR) in 47 homozygous D6-wt EM was 0.28 (0.11–4.10) and the corresponding value in heterozygous EM was 0.36 (0.11–9.10). The median difference was 0.09 (95% confidence interval: 0.02–0.16). CYP2D6 phenotyping is a promising tool in tailoring the individual dose of tricyclic antidepressants, some neuroleplics and some antiarrhythmics. However if the genotype test could be improved with regard to both sensitivity in PM and the ability to predict CYP2D6 activity in EM then it would be of even greater clinical value in therapeutic drug monitoring. 相似文献
39.
F Leonessa V Boulay A Wright E W Thompson N Brünner R Clarke 《Acta oncologica (Stockholm, Sweden)》1992,31(2):115-123
Many breast tumors appear to follow a predictable clinical pattern, being initially responsive to endocrine therapy and to cytotoxic chemotherapy but ultimately exhibiting a phenotype resistant to both modalities. Using the MCF-7 human breast cancer cell line as an example of an 'early' phenotype (estrogen and progesterone receptor positive, steroid responsive, low metastatic potential), we have isolated and characterized a series of hormone-independent but hormone-responsive variants (MIII and MCF7/LCC1). However, these variants remain responsive to both antiestrogens and cytotoxic drugs (methotrexate and colchicine). MIII and MCF7/LCC1 cells appear to mimic some of the critical aspects of the early progression to a more aggressive phenotype. An examination of the phenotype of these cells suggests that some hormone-independent breast cancer cells are derived from hormone-dependent parental cells. The development of a hormone-independent phenotype can arise independently of acquisition of a cytotoxic drug resistant phenotype. 相似文献
40.